Often overlooked, adjuvants from GlaxoSmithKline and others can be an essential part of an effective cancer vaccine and could help advance the field even further.
(Comment on this article at http://www.financialwire.net/2010/04/21/insurance-in-focus-generex-establishes-reimbursement-plan-for-oral-lyn/) April 21, 2010 (FinancialWire) -- Generex Biotechnology Corp. (NASDAQ: GNBT) …
Generex Biotechnology Corp. (OTC:GNBT) announced that it entered into an agreement to sell 2,575 shares of the company’s newly designated non-voting series A 9% convertible preferred stock and warrants in a deal estimated at …
26.74 13.61 ... ... DryShips DRYS 7.10 +.02 91.53 2.72 +.3 -92.1 FifthThird FITB 7.25 +.12 .04 21.00 1.01 +1.7 -57.6 GenBiotc h GNBT .75 -.06 1.14 .08 -7.4 -24.3 Intel INTC 15.92 ... .56 24.75 12.05 ... -31.0 Microsoft MSFT 22.05 -.09 …
It wasn't hard for investors to find gains in 2013. This year is different – unless you're invested in one or more companies on this growing hot penny stocks list boasting huge year-to-date gains. Leading the pack of 2014's surging low-priced …